Search - tctmd.com

Displaying 621 - 640 of 640

Sort: Relevancy | Date

News Daily News

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Caitlin E. Cox

April 12, 2012

News Daily News

Baseline Anemia Raises Risk for Stent Thrombosis After DES

L.A. McKeown

April 04, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Daily News

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Yael L. Maxwell

February 20, 2012

News Daily News

Iodinated Contrast Agents Tied to Potential Thyroid Dysfunction

Yael L. Maxwell

January 30, 2012

News Daily News

Similar Mortality Rates Seen in Men and Women with NSTE ACS

L.A. McKeown

January 26, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

News Daily News

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Yael L. Maxwell

December 14, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Local-Regional Anesthesia Better Than General for EVAR

L.A. McKeown

July 22, 2011

News Daily News

CREST Subanalysis Stirs Controversy Regarding Possible Gender Differences

L.A. McKeown

May 10, 2011

News Daily News

The COURAGE Effect: Sustained Decline Seen in PCI for Stable Angina

Jason Kahn

April 25, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Caitlin E. Cox

April 20, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Daily News

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

L.A. McKeown

February 28, 2011

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Leah Lawrence

February 03, 2011

CME

Advertisement

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Baseline Anemia Raises Risk for Stent Thrombosis After DES

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Iodinated Contrast Agents Tied to Potential Thyroid Dysfunction

Similar Mortality Rates Seen in Men and Women with NSTE ACS

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

SCAAR: Second-Generation DES Improve Hard Outcomes

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Local-Regional Anesthesia Better Than General for EVAR

CREST Subanalysis Stirs Controversy Regarding Possible Gender Differences

The COURAGE Effect: Sustained Decline Seen in PCI for Stable Angina

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content